(Q31028126)

English

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial (English)

1 reference

Europe PubMed Central

15 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Gerhardt Attard

object named as

Gerhardt Attard

10

0 references

Matthew R Sydes

object named as

Matthew R Sydes

23

0 references

object named as

Noel W Clarke

3

0 references

object named as

Daniel S Engeler

13

0 references

11

object named as

Johann S de Bono

1 reference

Europe PubMed Central

15 August 2017

STAMPEDE Investigators

24

object named as

STAMPEDE Investigators

1 reference

Europe PubMed Central

15 August 2017

David P Dearnaley

4

object named as

David P Dearnaley

1 reference

Europe PubMed Central

15 August 2017

Melissa L Spear

2

object named as

Melissa R Spears

1 reference

Europe PubMed Central

15 August 2017

12

object named as

Alison Birtle

1 reference

Europe PubMed Central

15 August 2017

14

object named as

Tony Elliott

1 reference

Europe PubMed Central

15 August 2017

Joseph Albert Sullivan

16

object named as

Joe O'Sullivan

1 reference

Europe PubMed Central

15 August 2017

Narayanan N Srihari

18

object named as

Narayanan Srihari

1 reference

Europe PubMed Central

15 August 2017

Mahesh K B Parmar

22

object named as

Mahesh K B Parmar

1 reference

Europe PubMed Central

15 August 2017

Francesca Schiavone

9

object named as

Francesca Schiavone

1 reference

Europe PubMed Central

15 August 2017

author name string

Nicholas D James

1

1 reference

Europe PubMed Central

15 August 2017

Malcolm D Mason

5

1 reference

Europe PubMed Central

15 August 2017

Christopher C Parker

6

1 reference

Europe PubMed Central

15 August 2017

Alastair W S Ritchie

7

1 reference

Europe PubMed Central

15 August 2017

J Martin Russell

8

1 reference

Europe PubMed Central

15 August 2017

David Matheson

15

1 reference

Europe PubMed Central

15 August 2017

Delia Pudney

17

1 reference

Europe PubMed Central

15 August 2017

Jan Wallace

19

1 reference

Europe PubMed Central

15 August 2017

Jim Barber

20

1 reference

Europe PubMed Central

15 August 2017

Isabel Syndikus

21

1 reference

Europe PubMed Central

15 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 November 2015

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

2

1 reference

Europe PubMed Central

15 August 2017

348-357

1 reference

Europe PubMed Central

15 August 2017

3

1 reference

Europe PubMed Central

15 August 2017

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Landmark analysis at the 25-year landmark point

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Landmark survival as an end-point for trials in critically ill patients--comparison of alternative durations of follow-up: an exploratory analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Speeding up the evaluation of new agents in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

21 June 2018

Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

25 November 2018

Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

25 November 2018

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

25 November 2018

Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

25 November 2018

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789485

25 November 2018

Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/26606329

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer r

1 reference

https://pubmed.ncbi.nlm.nih.gov/26606329

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26606329

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMAONCOL.2015.4350

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31028126&oldid=1966873150"